$122.00
Tesamorelin is a stabilized GHRH analogue bearing a trans-3-hexenoyl modification that resists DPP-4 cleavage. It carries the deepest clinical evidence base of any GHRH analogue, developed for visceral-adiposity research in HIV-associated lipodystrophy.
| Product Format | 10mg vials |
|---|---|
| Vial Size | 10mg |
| Vial Capacity | 3 mL |
| Box Combinations | 20mg, 50mg, 100mg |
| Cost per milligram | $8.98 – $6.10 |
| Multi-vial Purity | 99.41% |
| Endotoxin Screening | PASSED |
| Heavy Metals Screening | PASSED |
| Purity Screening | PASSED |
| Doubly Validated | YES |
| Independently Tested | YES |
Allen Biotechnology Co Manufacturer ID: WF34
Batch ID: AM202632
CAS: 218949-48-5
Molecular Formula: C221H366N72O67S
For educational purposes only.
Phase 3 clinical research reported that tesamorelin reduced visceral adipose tissue versus placebo over 26-52 weeks in lipodystrophy populations, with preserved subcutaneous fat and pulsatile, feedback-regulated GH release.
Tesamorelin has late-stage trial data for visceral adipose tissue in a defined clinical population.
The N-terminal hexenoyl group protects the peptide from rapid DPP-4 degradation while retaining full GHRH-receptor activity, a design approach documented in its development literature.
The added N-terminal hexenoyl group protects GHRH from rapid degradation while preserving receptor activity.
Tesamorelin is a stabilized GHRH analogue bearing a trans-3-hexenoyl modification that resists DPP-4 cleavage. It is sold strictly for laboratory research use — not for human or veterinary use.
The catalog specification lists 99.41% HPLC purity. Our testing policy also requires independent endotoxin, heavy-metals and sterility screening. The current certificate table and linked PDF are samples; a production certificate must match the batch ID printed on the vial.
Tesamorelin (10mg vials) is offered in 20mg, 50mg, 100mg boxes (2 × 10mg vials, 5 × 10mg vials, 10 × 10mg vials), priced $122.00 to $898.00 — the per-mg cost falls as box size increases.
Keep sealed lyophilized vials refrigerated at 2–8°C away from light (stable 24+ months). After reconstitution with bacteriostatic water, refrigerate and use within the study-validated window, typically 30 days; never freeze reconstituted solution.
No reviews yet for this product. Purchased it for your laboratory? Email sales@allenbiotechpeptides.com to share your experience.
Every saleable batch of Tesamorelin must have third-party certificates. The values and linked PDF below are samples, not documents for a current saleable batch. A production certificate must match the batch ID printed on the vial.
| Sample assay | Listed laboratory | Sample result | Sample file |
|---|---|---|---|
| HPLC Purity | Janoshik Analytical | 99.41% | View sample |
| Endotoxin (LAL) | Chemtos Laboratories | PASSED | View sample |
| Heavy Metals (ICP-MS) | Chemtos Laboratories | PASSED | View sample |
NOTICE: All information provided above is strictly for educational and informational purposes. These products are research chemicals intended exclusively for laboratory research. They are not approved for human consumption; do not ingest them.
By purchasing from Allen Biotechnology Co, you acknowledge that you are acquiring research chemicals. Only qualified and licensed professionals may handle this product.
Under no circumstances may this product be used as a drug, agricultural product, pesticide, food additive or household chemical. Misrepresenting it for any of those purposes is strictly prohibited by law. All website content is provided for educational use exclusively. Any form of introduction into the human or animal body is illegal.
Allen Biotechnology Co publishes its testing policy, provides a labeled sample certificate, and offers direct research support.
